In 2023, Rohto Pharmaceutical conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2023 | 2022 | 2021 | 2020-2019 |
|---|---|---|---|---|
Total Waste Generated | 2,567a | 2,456a | 2,909a | |
Total Waste Recovered | 1,866a | 1,512.17a | 1,647.58a | |
Total Hazardous Waste Generated | N/A | N/A | N/A | |
Non-Hazardous Waste Disposed | N/A | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2023, Rohto Pharmaceutical generated a total of 2,567metric tonnes of waste.a
Of this amount, 72.69% of Rohto Pharmaceutical's total waste generated was recovered through methods such as recycling, reuse, or composting, while 27.31% was disposed of through landfilling, incineration, or combustion.a
In 2023, Rohto Pharmaceutical reported a total waste generation of 2,567 metric tonnes, of which 72.69% was recovered through recycling, reuse, or composting.This moderate level of recovery indicates that Rohto Pharmaceutical is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.a
Since 2019, Rohto Pharmaceutical's total waste generation decreased by 6.52%, yet rose by 4.52% in 2023, potentially indicating a temporary operational shift or inconsistency in waste management outcomes.a
Over the same period, Rohto Pharmaceutical's waste recovery rate increased by 18.06%.a